{"title":"Intravenous immune globulin for multiple sclerosis.","authors":"","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>This article is an executive summary of the Blue Cross Blue Shield Technology Evaluation Center (TEC) Assessment \"Intravenous Immune Globulin for Multiple Sclerosis\" Volume 9, No. 26, 1994. The complete assessment, which includes background information, methods, formulation of the assessment, review of evidence, conclusions, and references are available to Blue Cross Blue Shield TEC Program subscribers only. For subscription information, contact the program at (312) 440-6080.</p>","PeriodicalId":80184,"journal":{"name":"Tecnologica (Chicago, Ill.)","volume":" ","pages":"10"},"PeriodicalIF":0.0000,"publicationDate":"1995-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tecnologica (Chicago, Ill.)","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This article is an executive summary of the Blue Cross Blue Shield Technology Evaluation Center (TEC) Assessment "Intravenous Immune Globulin for Multiple Sclerosis" Volume 9, No. 26, 1994. The complete assessment, which includes background information, methods, formulation of the assessment, review of evidence, conclusions, and references are available to Blue Cross Blue Shield TEC Program subscribers only. For subscription information, contact the program at (312) 440-6080.
分享
京公网安备 11010802042870号
京ICP备2023020795号-1
求助内容：
应助结果提醒方式：
扫码关注我们
